Back

Semaphorin 4D levels in heart failure patients: do we have a novel biomarker of heart failure besides BNP?

30 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Biomarkers Inflammation HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Nadav Asher Willner

Rambam Health Care Campus, Haifa (Israel)

24 More presentations in this session

Presentation thumbnail
Associate Professor P. Lazarev (Moscow, RU)
Abstract Slides
Presentation thumbnail
Miss S. Stienen (Nijmegen, NL)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor J. Webb (London, GB)
Abstract
Presentation thumbnail
Professor F. Rutten (Utrecht, NL)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Biomarkers

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 08:30 CET
You may be interested in
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Effect of exercise training on NT-PRO-BNP plasma levels in patients with left ventricular systolic dysfunction after anterior st elevation myocardial infarction
29 June 2021
thumbnail
Congress Presentation
Myocardial MARK4 expression is increased in patients with impaired cardiac contractility and sleep-disordered breathing
1 September 2025
thumbnail
Congress Presentation
Elevated plasma amyloid, tau and neurofilament light chain suggest high prevalence of ongoing neurodegenerative processes in HFrEF and are linked to worse survival
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources